This trial is testing a combination of chemotherapy drugs with atezolizumab to see if it is more effective than chemotherapy alone in treating patients with stage III colon cancer. Atezolizumab is an immunotherapy drug that may help the body's immune system attack the cancer.
1 Primary · 2 Secondary · Reporting Duration: From the time from randomization to death, from any cause, assessed up to 5 years
700 Total Participants · 2 Treatment Groups
Primary Treatment: Atezolizumab · No Placebo Group · Phase 3
Age Any Age · All Participants · 10 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
|Cookeville Regional Medical Center||100.0%|